๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ ยท Real-Time Price ยท USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST

Jazz Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,7184,2684,0693,8343,6593,094
Revenue Growth
13.48%4.88%6.12%4.78%18.26%30.91%
Gross Profit
4,2983,9123,7583,5503,3922,877
Operating Income
1,2921,018864.14816.23839.14475.26
Net Income
205.95-356.15560.12414.83-224.06-329.67
Earnings Per Share
3.10-5.848.656.10-3.58-5.52
EPS Growth
--41.75%---

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Neuroscience
3,0842,8782,6982,7082,7612,335
Total Oncology
1,4201,1291,1111,015873.84733.81
Other Product
-14.1711.4713.856.649.8
High-Sodium Oxybate AG Royalty
172.6211.73217.5875.92--
Other Royalty and Contract
35.1834.0130.2121.3417.9515.24
Revenue (Total)
4,7184,2684,0693,8343,6593,094

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,8562,4422,9941,630881.48591.45
Total Debt
5,6455,4276,1675,8005,8176,174
Net Cash (Debt)
-2,789-2,985-3,173-4,170-4,936-5,583
Net Cash Growth
------
Net Cash Per Share
-41.82-48.96-48.07-57.86-78.92-93.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,6921,3561,3961,0921,272778.51
Capital Expenditures
-70.75-58.75-38.07-23.96-29.05-27.64
Free Cash Flow
1,6221,2971,3581,0681,243750.87
Free Cash Flow Growth
21.33%-4.48%27.13%-14.07%65.53%-15.12%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
91.10%91.67%92.36%92.59%92.70%92.97%
Operating Margin
27.39%23.86%21.24%21.29%22.93%15.36%
Pretax Margin
5.50%-14.73%11.52%7.69%-10.46%-3.67%
Profit Margin
4.37%-8.34%13.77%10.82%-6.12%-10.65%
FCF Margin
34.37%30.39%33.37%27.86%33.97%24.27%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
74.32-13.2918.67--
Forward PE
8.767.675.726.298.548.23
P/FCF Ratio
9.117.965.487.258.0710.43
PS Ratio
3.132.421.832.022.742.53